Ark Solutions Inc (KOSDAQ:203690)
4,425.00
-75.00 (-1.67%)
At close: Jan 22, 2025
Ark Solutions Revenue
Ark Solutions had revenue of 3.62B KRW in the quarter ending September 30, 2025, a decrease of -59.51%. This brings the company's revenue in the last twelve months to 21.50B, down -34.17% year-over-year. In the year 2024, Ark Solutions had annual revenue of 33.23B, down -10.81%.
Revenue (ttm)
21.50B
Revenue Growth
-34.17%
P/S Ratio
3.21
Revenue / Employee
390.83M
Employees
55
Market Cap
68.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.23B | -4.03B | -10.81% |
| Dec 31, 2023 | 37.25B | 10.68B | 40.18% |
| Dec 31, 2022 | 26.58B | -6.26B | -19.07% |
| Dec 31, 2021 | 32.84B | 15.14B | 85.60% |
| Dec 31, 2020 | 17.69B | 10.57B | 148.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cell Biotech | 50.65B |
| Choong Ang Vaccine Laboratory | 39.19B |
| Naturalendo Tech | 21.87B |
| PanGen Biotech | 15.27B |
| MOA Life Plus | 9.80B |
| HLB Pep | 4.89B |
| EyeGene | 4.10B |
| Quratis | 2.28B |